BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31150423)

  • 1. Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
    Spaggiari D; Desfontaine V; Cruchon S; Guinchard S; Vocat A; Blattes E; Pitteloud J; Ciullini L; Bardinet C; Ivanyuk A; Makarov V; Ryabova O; Buclin T; Cole ST; Decosterd LA
    PLoS One; 2019; 14(5):e0217139. PubMed ID: 31150423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine.
    Desfontaine V; Guinchard S; Marques S; Vocat A; Moulfi F; Versace F; Huser-Pitteloud J; Ivanyuk A; Bardinet C; Makarov V; Ryabova O; André P; Prod'Hom S; Chtioui H; Buclin T; Cole ST; Decosterd L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1215():123555. PubMed ID: 36563654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
    Courlet P; Spaggiari D; Desfontaine V; Cavassini M; Alves Saldanha S; Buclin T; Marzolini C; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121733. PubMed ID: 31374423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
    Mariandyshev AO; Khokhlov AL; Smerdin SV; Shcherbakova VS; Igumnova OV; Ozerova IV; Bolgarina AA; Nikitina NA
    Ter Arkh; 2020 Apr; 92(3):61-72. PubMed ID: 32598795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P; Alves Saldanha S; Cavassini M; Marzolini C; Choong E; Csajka C; Günthard HF; André P; Buclin T; Desfontaine V; Decosterd LA
    J Mass Spectrom; 2020 Jun; 55(6):e4506. PubMed ID: 32160389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis.
    Lee SJ; Desta KT; Eum SY; Dartois V; Cho SN; Bae DW; Shin SC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():138-43. PubMed ID: 26730550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantitation of delamanid (OPC-67683) and its eight metabolites in human plasma using UHPLC-MS/MS.
    Meng M; Smith B; Johnston B; Carter S; Brisson J; Roth SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():78-91. PubMed ID: 26319300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a novel oxazolidinone anti-tuberculosis OTB-658 and its metabolites in monkey blood by LC-MS/MS.
    Jiang J; Liu Y; Liu X; Zhang D; Huang H; Wang B; Sheng L; Li Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1167():122552. PubMed ID: 33588346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Kim HJ; Seo KA; Kim HM; Jeong ES; Ghim JL; Lee SH; Lee YM; Kim DH; Shin JG
    J Pharm Biomed Anal; 2015 Jan; 102():9-16. PubMed ID: 25218029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
    Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser diode thermal desorption atmospheric pressure chemical ionization tandem mass spectrometry applied for the ultra-fast quantitative analysis of BKM120 in human plasma.
    Lanshoeft C; Heudi O; Leuthold LA; Schlotterbeck G; Elbast W; Picard F; Kretz O
    Anal Bioanal Chem; 2014 Sep; 406(22):5413-23. PubMed ID: 24958346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry.
    Farid NA; McIntosh M; Garofolo F; Wong E; Shwajch A; Kennedy M; Young M; Sarkar P; Kawabata K; Takahashi M; Pang H
    Rapid Commun Mass Spectrom; 2007; 21(2):169-79. PubMed ID: 17154350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Vu DH; Bolhuis MS; Koster RA; Greijdanus B; de Lange WC; van Altena R; Brouwers JR; Uges DR; Alffenaar JW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5758-63. PubMed ID: 22926568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.
    Guerra Valero YC; Dorofaeff T; Roberts JA; Lipman J; Coulthard MG; Sparkes L; Wallis SC; Parker SL
    Anal Bioanal Chem; 2021 Jul; 413(17):4483-4491. PubMed ID: 34041575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry.
    Jourdil JF; Tonini J; Stanke-Labesque F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():1-9. PubMed ID: 23384531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.